On several occasions, I have commented on the importance of developing new business and financing models for the rapidly evolving areas of medical technology and biotech. These have included:
So Far, Venture Capital Relatively Unsuccessful in Biopharma (November 14, 2006)
A Time to Make Friends: More Partnerships in Biotech, Med Tech? (July 12, 2006)
Tech Convergence a Key Theme at Orthopedics Conference in Chicago (April 3, 2006)
via Thinking about Life Sciences: Biotech Med Tech Business Models: Investors, Patients Deserve Better
Tags: Biotechnology, Medical Technology, Ogan Gurel, Venture Capital
